These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1940119)

  • 1. Neuropathologic findings in patients receiving long-term vigabatrin therapy for chronic intractable epilepsy.
    Cannon DJ; Butler WH; Mumford JP; Lewis PJ
    J Child Neurol; 1991; Suppl 2():S17-24. PubMed ID: 1940119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin in refractory epilepsy in adults and its application in children.
    Dam M
    J Child Neurol; 1991; Suppl 2():S25-9. PubMed ID: 1940120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response study of vigabatrin in children with refractory epilepsy.
    Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
    J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vigabatrin in pediatric epilepsy--an open study.
    Uldall P; Alving J; Gram L; Beck S
    J Child Neurol; 1991; Suppl 2():S38-44. PubMed ID: 1940123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high-dose gamma-vinyl GABA (vigabatrin) administration on visual and somatosensory evoked potentials in dogs.
    Schroeder CE; Gibson JP; Yarrington J; Heydorn WE; Sussman NM; Arezzo JC
    Epilepsia; 1992; 33 Suppl 5():S13-25. PubMed ID: 1425496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-vinyl GABA (vigabatrin): clinical experience in adult and adolescent patients with intractable epilepsy.
    Reynolds EH
    Epilepsia; 1992; 33 Suppl 5():S30-4; discussion S34-5. PubMed ID: 1425498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and clinical pharmacology of vigabatrin.
    Richens A
    J Child Neurol; 1991; Suppl 2():S7-10. PubMed ID: 1940127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vigabatrin--a new antiepileptic agent].
    Nakken KO; Henriksen O; Johannessen SI
    Tidsskr Nor Laegeforen; 1994 Oct; 114(24):2843-4. PubMed ID: 7998031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and EEG/ERP brain mapping studies with vigabatrin in therapy refractory epileptic patients].
    Pfersmann D; Saletu B; Semlitsch HV; Anderer P; Dieterich HA
    Wien Med Wochenschr; 1993; 143(6):119-28. PubMed ID: 8517061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term vigabatrin therapy on selected neurotransmitter concentrations in cerebrospinal fluid.
    Ben-Menachem E; Persson LI; Mumford J; Haegele KD; Huebert N
    J Child Neurol; 1991; Suppl 2():S11-6. PubMed ID: 1719063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain.
    Sidhu RS; Del Bigio MR; Tuor UI; Seshia SS
    Exp Neurol; 1997 Apr; 144(2):400-5. PubMed ID: 9168839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin in childhood epilepsy.
    Dulac O; Chiron C; Luna D; Cusmai R; Pajot N; Beaumont D; Mondragon S
    J Child Neurol; 1991; Suppl 2():S30-7. PubMed ID: 1940122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological evidence of vacuolar myelinopathy in a child following vigabatrin administration.
    Horton M; Rafay M; Del Bigio MR
    J Child Neurol; 2009 Dec; 24(12):1543-6. PubMed ID: 19773459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
    Mrugacz M; Bakunowicz-Łazarczyk A
    Klin Oczna; 2003; 105(5):326-8. PubMed ID: 14746191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vigabatrin in the management of infantile epileptic syndromes.
    Appleton RE
    Neurology; 1993 Nov; 43(11 Suppl 5):S21-3. PubMed ID: 8232983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of gamma-vinyl-gamma-aminobutyric acid for control of epilepsy in dogs.
    Speciale J; Dayrell-Hart B; Steinberg SA
    J Am Vet Med Assoc; 1991 Mar; 198(6):995-1000. PubMed ID: 2032927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient brain magnetic resonance imaging hyperintensity in basal ganglia and brain stem of epileptic infants treated with vigabatrin.
    Milh M; Villeneuve N; Chapon F; Pineau S; Lamoureux S; Livet MO; Bartoli C; Hugonenq C; Mancini J; Chabrol B; Girard N
    J Child Neurol; 2009 Mar; 24(3):305-15. PubMed ID: 19258289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin: a new antiepileptic medication.
    Mumford J; Dulac O
    J Child Neurol; 1991; Suppl 2():S3-6. PubMed ID: 1940121
    [No Abstract]   [Full Text] [Related]  

  • 19. [Visual field changes secondary to vigabatrin treatment].
    Mauri-Llerda JA; Iñiguez C; Tejero-Juste C; Santos-Lasaosa S; Escalza-Cortina I; Ascaso-Puyuelo J; Abad-Alegría F; Morales-Asín F
    Rev Neurol; 2000 Dec 16-31; 31(12):1104-8. PubMed ID: 11205539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability.
    Ylinen A
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():46-9. PubMed ID: 10030432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.